Literature DB >> 22239881

The paradox of muscle hypertrophy in muscular dystrophy.

Joe N Kornegay1, Martin K Childers, Daniel J Bogan, Janet R Bogan, Peter Nghiem, Jiahui Wang, Zheng Fan, James F Howard, Scott J Schatzberg, Jennifer L Dow, Robert W Grange, Martin A Styner, Eric P Hoffman, Kathryn R Wagner.   

Abstract

Mutations in the dystrophin gene cause Duchenne and Becker muscular dystrophy in humans and syndromes in mice, dogs, and cats. Affected humans and dogs have progressive disease that leads primarily to muscle atrophy. Mdx mice progress through an initial phase of muscle hypertrophy followed by atrophy. Cats have persistent muscle hypertrophy. Hypertrophy in humans has been attributed to deposition of fat and connective tissue (pseudohypertrophy). Increased muscle mass (true hypertrophy) has been documented in animal models. Muscle hypertrophy can exaggerate postural instability and joint contractures. Deleterious consequences of muscle hypertrophy should be considered when developing treatments for muscular dystrophy.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22239881      PMCID: PMC5951392          DOI: 10.1016/j.pmr.2011.11.014

Source DB:  PubMed          Journal:  Phys Med Rehabil Clin N Am        ISSN: 1047-9651            Impact factor:   1.784


  132 in total

1.  Reliability of goniometry in Labrador Retrievers.

Authors:  Gayle Jaegger; Denis J Marcellin-Little; David Levine
Journal:  Am J Vet Res       Date:  2002-07       Impact factor: 1.156

2.  Computed tomography of the skeletal musculature in Becker-type muscular dystrophy and benign infantile spinal muscular atrophy.

Authors:  M de Visser; B Verbeeten
Journal:  Muscle Nerve       Date:  1985-06       Impact factor: 3.217

Review 3.  The function of Myostatin and strategies of Myostatin blockade-new hope for therapies aimed at promoting growth of skeletal muscle.

Authors:  Ketan Patel; Helge Amthor
Journal:  Neuromuscul Disord       Date:  2005-01-11       Impact factor: 4.296

4.  Juvenile-onset distal myopathy in Rottweiler dogs.

Authors:  S M Hanson; M O Smith; T L Walker; G D Shelton
Journal:  J Vet Intern Med       Date:  1998 Mar-Apr       Impact factor: 3.333

5.  Enlargement of the tongue and changes in the jaws with muscular dystrophy.

Authors:  G M Ardran; A Hamilton; F H Kemp
Journal:  Clin Radiol       Date:  1973-07       Impact factor: 2.350

6.  The cranial sartorius muscle undergoes true hypertrophy in dogs with golden retriever muscular dystrophy.

Authors:  Joe N Kornegay; Diane D Cundiff; Daniel J Bogan; Janet R Bogan; Carol S Okamura
Journal:  Neuromuscul Disord       Date:  2003-08       Impact factor: 4.296

7.  Muscle development in mdx mutant mice.

Authors:  J Dangain; G Vrbova
Journal:  Muscle Nerve       Date:  1984 Nov-Dec       Impact factor: 3.217

8.  Spasticity.

Authors:  R R Young; A W Wiegner
Journal:  Clin Orthop Relat Res       Date:  1987-06       Impact factor: 4.176

9.  The pathomechanics of gait in Duchenne muscular dystrophy.

Authors:  D H Sutherland; R Olshen; L Cooper; M Wyatt; J Leach; S Mubarak; P Schultz
Journal:  Dev Med Child Neurol       Date:  1981-02       Impact factor: 5.449

10.  Canine X-linked muscular dystrophy: morphologic lesions.

Authors:  B A Valentine; B J Cooper; J F Cummings; A de Lahunta
Journal:  J Neurol Sci       Date:  1990-06       Impact factor: 3.181

View more
  46 in total

1.  High prevalence of plasma lipid abnormalities in human and canine Duchenne and Becker muscular dystrophies depicts a new type of primary genetic dyslipidemia.

Authors:  Zoe White; Chady H Hakim; Marine Theret; N Nora Yang; Fabio Rossi; Dan Cox; Gordon A Francis; Volker Straub; Kathryn Selby; Constadina Panagiotopoulos; Dongsheng Duan; Pascal Bernatchez
Journal:  J Clin Lipidol       Date:  2020-05-29       Impact factor: 4.766

2.  Lack of the serum- and glucocorticoid-inducible kinase SGK1 improves muscle force characteristics and attenuates fibrosis in dystrophic mdx mouse muscle.

Authors:  Martin Steinberger; Michael Föller; Silke Vogelgesang; Mirjam Krautwald; Martin Landsberger; Claudia K Winkler; Joachim Kasch; Ernst-Martin Füchtbauer; Dietmar Kuhl; Jakob Voelkl; Florian Lang; Heinrich Brinkmeier
Journal:  Pflugers Arch       Date:  2014-11-14       Impact factor: 3.657

3.  UCHL1 regulates muscle fibers and mTORC1 activity in skeletal muscle.

Authors:  Hongbo Gao; Jessica Freeling; Penglong Wu; Ashley P Liang; Xuejun Wang; Yifan Li
Journal:  Life Sci       Date:  2019-07-26       Impact factor: 5.037

4.  Immunohistochemical and ultrastructural analysis of sporadic inclusion body myositis: a case series.

Authors:  Katarzyna Haczkiewicz; Agata Sebastian; Aleksandra Piotrowska; Maria Misterska-Skóra; Agnieszka Hałoń; Marta Skoczyńska; Maciej Sebastian; Piotr Wiland; Piotr Dzięgiel; Marzenna Podhorska-Okołów
Journal:  Rheumatol Int       Date:  2018-12-08       Impact factor: 2.631

5.  Variable cytoplasmic actin expression impacts the sensitivity of different dystrophin-deficient mdx skeletal muscles to eccentric contraction.

Authors:  Angus Lindsay; William M Southern; Preston M McCourt; Alexie A Larson; James S Hodges; Dawn A Lowe; James M Ervasti
Journal:  FEBS J       Date:  2019-04-11       Impact factor: 5.542

6.  Functional disruption of the dystrophin gene in rhesus monkey using CRISPR/Cas9.

Authors:  Yongchang Chen; Yinghui Zheng; Yu Kang; Weili Yang; Yuyu Niu; Xiangyu Guo; Zhuchi Tu; Chenyang Si; Hong Wang; Ruxiao Xing; Xiuqiong Pu; Shang-Hsun Yang; Shihua Li; Weizhi Ji; Xiao-Jiang Li
Journal:  Hum Mol Genet       Date:  2015-04-09       Impact factor: 6.150

7.  Rapid depletion of muscle progenitor cells in dystrophic mdx/utrophin-/- mice.

Authors:  Aiping Lu; Minakshi Poddar; Ying Tang; Jonathan D Proto; Jihee Sohn; Xiaodong Mu; Nicholas Oyster; Bing Wang; Johnny Huard
Journal:  Hum Mol Genet       Date:  2014-04-29       Impact factor: 6.150

Review 8.  Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials.

Authors:  Joe N Kornegay; Christopher F Spurney; Peter P Nghiem; Candice L Brinkmeyer-Langford; Eric P Hoffman; Kanneboyina Nagaraju
Journal:  ILAR J       Date:  2014

9.  Peroxisome proliferator-activated receptor γ coactivator1- gene α transfer restores mitochondrial biomass and improves mitochondrial calcium handling in post-necrotic mdx mouse skeletal muscle.

Authors:  Richard Godin; Frederic Daussin; Stefan Matecki; Tong Li; Basil J Petrof; Yan Burelle
Journal:  J Physiol       Date:  2012-08-20       Impact factor: 5.182

10.  Characteristics of magnetic resonance imaging biomarkers in a natural history study of golden retriever muscular dystrophy.

Authors:  Zheng Fan; Jiahui Wang; Mihye Ahn; Yael Shiloh-Malawsky; Nizar Chahin; Sandra Elmore; C Robert Bagnell; Kathy Wilber; Hongyu An; Weili Lin; Hongtu Zhu; Martin Styner; Joe N Kornegay
Journal:  Neuromuscul Disord       Date:  2013-10-30       Impact factor: 4.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.